FDMT vs VRTX: Which Stock is Better?
Side-by-side comparison of 4D Molecular Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
FDMT
4D Molecular Therapeutics Inc
$8.46
VRTX
Vertex Pharmaceuticals Inc
$474.27
Key Metrics Comparison
| Metric | FDMT | VRTX | Winner |
|---|---|---|---|
| Market Cap | $533.07M | $123.45B | VRTX |
| P/E Ratio | N/A | 31.75 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 29.0% | 0.1% | FDMT |
| Gross Margin | -148295.8% | 53.7% | VRTX |
Analyze FDMT
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FDMT or VRTX a better investment?
Comparing FDMT and VRTX: 4D Molecular Therapeutics Inc has a market cap of $533.07M while Vertex Pharmaceuticals Inc has $123.45B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FDMT and VRTX?
FDMT (4D Molecular Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FDMT or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: FDMT or VRTX?
FDMT has higher revenue growth at 29.0% vs 0.1% for VRTX.
Which company is more profitable: FDMT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -148295.8% for FDMT.
Which is the larger company: FDMT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $123.45B compared to $533.07M for FDMT.
Should I buy FDMT or VRTX in 2026?
Both FDMT and VRTX have investment merit. FDMT trades at $8.46 while VRTX trades at $474.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FDMT and VRTX stock?
Key differences: Market Cap ($533.07M vs $123.45B), P/E Ratio (N/A vs 31.7x), Revenue Growth (29.0% vs 0.1%), Gross Margin (-148295.8% vs 53.7%).